Using a threshold of >5-fold T cell expansion during stimulation with CD3/CD28 beads as a marker for “healthy” effector function, we demonstrate that 57% of osteosarcoma samples in this study had >5-fold T cell expansion, compared to 0% of Ewing sarcoma (Figure 6). The gene discussed is CD28; the disease is Ewing sarcoma.